HBK Investments’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

HBK Investments’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-553,700	Closed	-$5.54M	–	379
2022 Q3	$5.54M	Hold	553,700	–	–	0.04%	177
2022 Q2	$5.48M	Buy	553,700 +3,700	+0.7%	+$36.5K	0.03%	207
2022 Q1	$5.42M	Hold	550,000	–	–	0.02%	239
2021 Q4	$5.39M	Hold	550,000	–	–	0.02%	248
2021 Q3	$5.4M	Hold	550,000	–	–	0.02%	246
2021 Q2	$5.44M	Hold	550,000	–	–	0.02%	275
2021 Q1	$5.65M	Buy	+550,000	New	+$6.11M	0.03%	226

HBK Investments's LUXA Position: Q4 2022 in Review

HBK Investments sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 553,700 shares — an estimated $5.54M sold.

HBK Investments first reported a position in LUXA in Q1 2021 and held it in 7 quarters. The position peaked at $5.65M in Q1 2021. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

HBK Investments reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
HBK Investments sold 553,700 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $5.54M.
HBK Investments first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 7 quarters.
HBK Investments's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $5.65M in Q1 2021.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on HBK Investments's 13F filing for Q4 2022, filed 14 Feb 2023.